ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Advanced Search

Autologous Expanded Tregs Promote Bone Marrow Engraftment and Donor Kidney Survival in Non-Human Primate Chimerism Model

K. Bruestle1, P. Alonso-Guallart1, H. Sakai1, F. Fredriksson1, B. Piegari1, E. Lopes1, G. Pierre1, A. Shou1, D. Ekanayake-Alper1, J. Weiner1, A. Iuga2, S. M. Coley2, M. Sykes1, A. Griesemer1

1Columbia Center for Translational Immunology, Columbia University, New York City, NY, 2Department of Pathology and Cell Biology, Columbia University, New York City, NY

Meeting: 2020 American Transplant Congress

Abstract number: A-381

Keywords: Graft survival, Kidney transplantation, T cells, Tolerance

Session Information

Date: Saturday, May 30, 2020

Session Name: Poster Session A: Tolerance / Immune Deviation

Session Time: 3:15pm-4:00pm

 Presentation Time: 3:30pm-4:00pm

Location: Virtual

Related Abstracts
  • Treg And Bone Marrow Infusion Promotes Survival Of Donor Kidney Grafted Months After Disappearance Of Mixed Chimerism
  • Autologous Expanded Tregs and Porcine Hematopoietic Cells to Prolong Xenogeneic Pig Skin Graft Acceptance in Baboons.

*Purpose: Mixed chimerism (MC) induced with non-myeloablative conditioning in monkeys and humans induces tolerance to 70% of kidney grafts transplanted at the time of BMT. We use ex vivo expanded, polyclonal host Tregs to improve MC induction. To test tolerance, we waited 120 days before grafting donor kidneys in the abscence of immunosuppression (IS), as such grafts are routinely rejected by animals receiving BMT without Tregs.

*Methods: Host Tregs were grown from sorted (CD4+ CD25hi) PBMCs and cryopreserved. Conditioning included total body irradiation (125cGy), thymic irradiation (7Gy), anti-CD154 mAbs, horse ATG, loCD2 mAbs, followed by allogeneic MHC-mismatched BMT and 1 month of rapamycin, after which all immunosuppression (IS) was withdrawn. 8 cynomolgous macaques underwent this regimen, of which 4 received Treg infusions and donor kidney grafted on day 120.

*Results: Transient peripheral blood macrochimerism was seen in all animals for 30 to 60 days after BMT. Treg animals showed bone marrow engraftment on day 50, anti-donor hyporesponsiveness in MLR and Elispot, an overall higher level of peak chimerism and no signs of graft-versus-host disease. In the longest survivor, MLR assays showed antidonor hyporesponsiveness that was restored in CD25-depleted MLR. This animal also showed a larger Treg population in proliferating anti-donor T cells versus anti-third party T cells in a CFSE stained MLR. Treg animals had kidney graft survival up to 222 days without IS. In contrast, control animals demonstrated donor-specific antibodies and rejected their kidney graft within 3 days.

*Conclusions: Autologous, ex vivo expanded Tregs in combination with iliac crest BMT results in prolonged survival of donor kidneys grafted after peripheral chimerism is lost. Ex vivo expanded, polyclonal Tregs given at the time of BMT not only enhance donor chimerism but may induce a regulatory environment that is associated with robust operational tolerance to the donor.

 border=

 border=

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Bruestle K, Alonso-Guallart P, Sakai H, Fredriksson F, Piegari B, Lopes E, Pierre G, Shou A, Ekanayake-Alper D, Weiner J, Iuga A, Coley SM, Sykes M, Griesemer A. Autologous Expanded Tregs Promote Bone Marrow Engraftment and Donor Kidney Survival in Non-Human Primate Chimerism Model [abstract]. Am J Transplant. 2020; 20 (suppl 3). https://atcmeetingabstracts.com/abstract/autologous-expanded-tregs-promote-bone-marrow-engraftment-and-donor-kidney-survival-in-non-human-primate-chimerism-model/. Accessed March 8, 2021.

« Back to 2020 American Transplant Congress

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Home
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Search
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Home
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Penis Transplantation: First U.S. Experience.
  • A Decade of Donor-Derived Disease: A Report of the OPTN Ad Hoc Disease Transmission Advisory Committee (DTAC).
  • Penis Transplantation: First U.S. Experience.
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Evidence of a Clinically Significant Drug-Drug Interaction between Cannabidiol and Tacrolimus: A Case Report
  • Kidney Dialysis after Heart Transplantation: The Short and Long Term Outcomes

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2021 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.